Sacred Leaf Spring

06/15/2026

Don’t forget about your fur babies this week with the storms:) We have treat and tincture options! Happy to assist with dosing!

06/15/2026

A U.S. cannabis company is going to list on the New York Stock Exchange.

Florida-based Trulieve Cannabis Corp. has made history as the first U.S. plant-touching cannabis operator to trade on the New York Stock Exchange (NYSE), debuting under the ticker symbol "TRLV."

Historically, the federal classification of ma*****na as a Schedule I substance shut major domestic businesses out of Wall Street, forcing them to trade on smaller, over-the-counter markets or in Canada. However, following the federal government's decision in April 2026 to reclassify state-licensed medical ma*****na to Schedule III, the regulatory landscape shifted dramatically.

To clear the NYSE's compliance hurdles, Trulieve structured its business so that its listed entity consists exclusively of state-licensed medical operations, marking a pivotal moment for mainstream financial integration.

This corporate breakthrough and policy shift carry immense implications far beyond the stock market. For decades, the rigorous restrictions on Schedule I drugs severely hindered clinical research, leaving universities and scientists facing massive regulatory barriers to study the efficacy of cannabis.

Under Schedule III, researchers face far fewer restrictions, paving the way for comprehensive clinical trials to evaluate the drug's impact on chronic pain, neurological disorders, and other conditions. For both Wall Street investors and the scientific community, the next era of the cannabis industry will likely be defined by rigorous research, clinical data, and corporate legitimacy rather than political debates.

source: Wilson, M. R. (2026). Health Brief: Trump’s cannabis shift reaches Wall Street. WP Intelligence.

05/29/2026

05/23/2026

05/19/2026

Sativa vs Indica

05/15/2026

A lot is happening in Texas h**p right now, and misinformation spreads fast.

The biggest thing to understand: not every court deadline means an immediate change in enforcement or legality.

We’re continuing to monitor both the THBC vs DSHS case and the Sky Marketing Delta-8 injunction closely and will keep the industry updated as developments happen.

Businesses should stay informed, stay compliant, and prepare for multiple outcomes as these cases continue to unfold.

05/12/2026

https://youtu.be/UlFtIWwqc4E

We sit down with Wyatt Larew, founder of Wyatt Purp, for a deep, unfiltered conversation about the real conflicts shaping medical ma*****na, cannabis and hem...

05/10/2026

www.TxCannabisCo.com